135 related articles for article (PubMed ID: 22380773)
21. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.
Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA
Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123
[TBL] [Abstract][Full Text] [Related]
22. 3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.
Burke WJ
Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):143-8. PubMed ID: 12769806
[TBL] [Abstract][Full Text] [Related]
23. Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts.
Yoval-Sánchez B; Rodríguez-Zavala JS
Chem Res Toxicol; 2012 Mar; 25(3):722-9. PubMed ID: 22339434
[TBL] [Abstract][Full Text] [Related]
24. Alda-1 modulates the kinetic properties of mitochondrial aldehyde dehydrogenase (ALDH2).
Belmont-Díaz JA; Yoval-Sánchez B; Calleja-Castañeda LF; Pardo Vázquez JP; Rodríguez-Zavala JS
FEBS J; 2016 Oct; 283(19):3637-3650. PubMed ID: 27521998
[TBL] [Abstract][Full Text] [Related]
25. Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells.
Ding J; Zhang Q; Luo Q; Ying Y; Liu Y; Li Y; Wei W; Yan F; Zhang H
Crit Care Med; 2016 Jul; 44(7):e544-52. PubMed ID: 26757166
[TBL] [Abstract][Full Text] [Related]
26. Differential metabolism of organic nitrates by aldehyde dehydrogenase 1a1 and 2: substrate selectivity, enzyme inactivation, and active cysteine sites.
Tsou PS; Page NA; Lee SG; Fung SM; Keung WM; Fung HL
AAPS J; 2011 Dec; 13(4):548-55. PubMed ID: 21818694
[TBL] [Abstract][Full Text] [Related]
27. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.
Chen CH; Budas GR; Churchill EN; Disatnik MH; Hurley TD; Mochly-Rosen D
Science; 2008 Sep; 321(5895):1493-5. PubMed ID: 18787169
[TBL] [Abstract][Full Text] [Related]
28. Mitigation of radiation-induced dermatitis by activation of aldehyde dehydrogenase 2 using topical alda-1 in mice.
Ning S; Budas GR; Churchill EN; Chen CH; Knox SJ; Mochly-Rosen D
Radiat Res; 2012 Jul; 178(1):69-74. PubMed ID: 22404739
[TBL] [Abstract][Full Text] [Related]
29. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
Morgan CA; Hurley TD
Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
[TBL] [Abstract][Full Text] [Related]
30. Adducts of propiolaldehyde and 3,4-dihydroxyphenylacetaldehyde with human aldehyde dehydrogenase.
Pietruszko R; MacKerell AD; Ferencz-Biro K
Prog Clin Biol Res; 1985; 183():67-74. PubMed ID: 4048184
[No Abstract] [Full Text] [Related]
31. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase.
Marchitti SA; Deitrich RA; Vasiliou V
Pharmacol Rev; 2007 Jun; 59(2):125-50. PubMed ID: 17379813
[TBL] [Abstract][Full Text] [Related]
32. Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1).
Collard F; Vertommen D; Fortpied J; Duester G; Van Schaftingen E
Biochimie; 2007 Mar; 89(3):369-73. PubMed ID: 17175089
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment with the ALDH2 agonist Alda-1 reduces intestinal injury induced by ischaemia and reperfusion in mice.
Zhu Q; He G; Wang J; Wang Y; Chen W
Clin Sci (Lond); 2017 Jun; 131(11):1123-1136. PubMed ID: 28325855
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological chaperone therapies: Can aldehyde dehydrogenase activator make us healthier?
Dollé L; Gao B
J Hepatol; 2015 Jun; 62(6):1228-30. PubMed ID: 25681554
[No Abstract] [Full Text] [Related]
35. Gene array profiles of alcohol and aldehyde metabolizing enzymes in brains of C57BL/6 and DBA/2 mice.
Bhave SV; Hoffman PL; Lassen N; Vasiliou V; Saba L; Deitrich RA; Tabakoff B
Alcohol Clin Exp Res; 2006 Oct; 30(10):1659-69. PubMed ID: 17010133
[TBL] [Abstract][Full Text] [Related]
36. A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity.
Yasgar A; Titus SA; Wang Y; Danchik C; Yang SM; Vasiliou V; Jadhav A; Maloney DJ; Simeonov A; Martinez NJ
PLoS One; 2017; 12(1):e0170937. PubMed ID: 28129349
[TBL] [Abstract][Full Text] [Related]
37. New insights into the half-of-the-sites reactivity of human aldehyde dehydrogenase 1A1.
Yoval-Sánchez B; Pardo JP; Rodríguez-Zavala JS
Proteins; 2013 Aug; 81(8):1330-9. PubMed ID: 23444097
[TBL] [Abstract][Full Text] [Related]
38. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
[TBL] [Abstract][Full Text] [Related]
39. Human brain aldehyde dehydrogenase: activity with DOPAL and isozyme distribution.
Hafer G; Agarwal DP; Goedde HW
Alcohol; 1987; 4(5):413-8. PubMed ID: 3675864
[TBL] [Abstract][Full Text] [Related]
40. Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice.
Li M; Xu M; Li J; Chen L; Xu D; Tong Y; Zhang J; Wu H; Kong X; Xia Q
J Immunol Res; 2018; 2018():9807139. PubMed ID: 30671488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
